Results 121 to 130 of about 7,521 (213)

[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].

The Korean journal of hepatology, 2006
Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We thought that the host immune response is important to prevent viral relapse.
Chun Kyon, Lee, Kwang-Hyub, Han, Jeong Hun, Suh, Young Suk, Cho, Sun Young, Won, Chae Yoon, Chon, Young Myoung, Moon, In Suh, Park   +7 more
openaire   +1 more source

Early Serum HBV pgRNA and HBeAg Drop combinedly Predicted HBeAg Seroconversion in Chinese Patients Treated with Entecavir or Interferon

, 2020
Figure S1. The relationship between serum HBV pgRNA and HBsAg or HBeAg levels in all patients. (A) The correlation between serum pgRNA and HBsAg levels at baseline. (B) The correlation between serum pgRNA and HBsAg levels at week 48. (C) The correlation between serum pgRNA and HBeAg levels at baseline.
openaire   +1 more source

CORE MUTATIONS IN THE HBEAG-NEGATIVE STAGE ARE KEY DETERMINANTS OF HEPATITIS B VIRUS REPLICATION

Annals of Hepatology
Introduction and Objectives: The natural history of chronic HBV infection is characterized by distinct stages resulting from virus-host interactions. In this context, a late and pivotal event is HBeAg seroconversion, marked by the abrogation of HBeAg ...
Selene Leuzzi, Cecilia Garcia, Diego Flichman, Maria Mercedes Elizalde   +3 more
doaj   +1 more source

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand [PDF]

, 2014

core   +1 more source

Fibrosis in chronic viral hepatitis [PDF]

, 2011
Alter, Antonio Craxì, Aranzabal, Bellentani, Benhamou, Benvegnú, Bodsworth, Bonacini, Bortolotti, Bruno, Bruno, Bruno, Bruno, Bruno, Cammà, Chang, Chang, Chang, Chen, Corrao, Corrao, Das, de Jongh, Di Marco, Dienstag, Dienstag, Dunn, D’Amico, D’Souza, Eyster, Fattovich, Fattovich, Fattovich, Fattovich, Feld, Fontana, Fried, Fujiwara, Fung, Fung, George, Graham, Hadziyannis, Heathcote, Hu, Iloeje, Janssen, Kellerman, Kuo, Kweon, Lai, Lampertico, Lau, Lavanchy, Liaw, Liaw, Liaw, Macías, Maida, Maini, Malekzadeh, Mallet, Manensis, Mani, Marcellin, Marcellin, Marcellin, Marcellin, Maylin, Mehta, Miailhes, Mocroft, Monto, Nguyen, Ortiz, Park, Perrillo, Perrillo, Persico, Peters, Peters, Pol, Pontisso, Poynard, Poynard, Poynard, Puoti, Qurishi, Rang, Rincon, Roberts, Roffi, Ruiz-Moreno, Sata, Schiff, Seeff, Serfaty, Shao, Shiratori, Shiratori, Soriano, Soto, Sterling, Sulkowski, Sulkowski, Thorburn, Tong, Tremolada, Tsang, Veldt, Veldt, Vincenza Calvaruso, Walewska-Zielecka, Wang, Weber, Yao, Yao, Yoshida, Zeuzem   +118 more
core   +1 more source

Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion. [PDF]

Viruses, 2019
Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T.   +12 more
europepmc   +1 more source

CS1-02 The Roleof HBV Viral Quasispeciesin HBeAg Seroconversion

International Journal of Infectious Diseases, 2009
openaire   +1 more source

TUBB1 promoter methylation is a promising biomarker for predicting HBeAg seroconversion in chronic hepatitis B. [PDF]

Microbiol Spectr
Zhao T, Tang Y, Sun Y, Li J, Fan Y, Cui C, Gao S, Wang K.   +7 more
europepmc   +1 more source

Evaluation of HBsAg and HBeAg seroconversion rates in patients diagnosed with chronic hepatitis B: A 10-year retrospective analysis. [PDF]

Saudi Med J
Toygar Deniz M, Fatih Karaşın M, Asena Doğan Öntaş İ, Akhan S.   +3 more
europepmc   +1 more source

Paternally Expressed Gene 10 Promoter Methylation Level as a Predictor of HBeAg Seroconversion in Chronic Hepatitis B Patients. [PDF]

J Med Virol
Luo P, Chen N, Tang Y, Wang J, Liu P, Fan Y, Liu H, Wang K.   +7 more
europepmc   +1 more source